Comparison of clinical outcomes between sorafenib and hepatic artery infusion chemotherapy in advanced hepatocellular carcinoma: A STROBE-compliant article.

Medicine (Baltimore) · 2018 · PMC5944539 · PMID 29703062

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significanceP = .07so close (0.05 < p ≤ 0.1)

[ 5 – 7 , 11 , 13 ] However, in our study, although the HAIC group tended to achieve higher DCR than the sorafenib group, it did not reach statistical significance (56.9% vs 38.6%, P = .07).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.